Cheryl Guttman Krader, BS, Pharm

Corneal surgery for Fuchs’ rejuvenates the endothelium rather than replacing it, and DSO is joining the lineup as a new treatment option.

During Refractive Day at ASCRS 2019, Julie Schallhorn, MD, MS, shed some new light on the topic by challenging conventional wisdom about dry eye and LASIK. 

A carefully packed surgical toolkit can optimize cataract surgery outcomes.

Follow-up at 7 years shows procedure safe, effective, provides stable correction

Improving vision, nonvisual function, quality of life key for customized treatment plans

Study and use of platelet preparation, other biologics viewed as next frontier

International panel shares overview of current and future applications, benefits, challenges

Clinical evaluation is basis for deciding whether additional imaging is needed

Latanoprostene bunod especially useful to patients who do not respond to first-line therapy

Ophthalmology benefiting from active programs for innovative product development in 2018 and onward

Surgeon provides overview of recent developments, applications with technology

Orbital and adnexal anatomy and pathology can affect IOP and its measurement as well as planning of glaucoma surgery, and these structures can be affected by medical and surgical treatment of glaucoma

A study of patients undergoing corneal crosslinking (CXL) for keratoconus suggests gene expression and tear inflammatory profile may be used as biomarkers to predict CXL outcomes.

In a study including data from 67 eyes, the majority of keratoconus indices measured by two commercially available Scheimpflug devices did not effectively differentiate normal high astigmatism from subclinical keratoconus.

Topical cenegermin has been approved by the FDA for the treatment of moderate-to-severe neurotrophic keratitis (NK), ushering in a breakthrough of management.

As more microinvasive glaucoma surgery (MIGS) procedures become available, surgeons are faced with decisions on adoption of new techniques.

The TECNIS Symfony IOL (J&J Vision) is breakthrough technology that is providing remarkable outcomes and driving a huge increase in the uptake of presbyopia-correcting IOLs among cataract surgery patients, according to Elizabeth Yeu, MD.

Residual astigmatism is not uncommon after toric IOL implantation. Depending on its cause and magnitude, lens reorientation may be a good solution.

Cataract surgery in eyes undergoing simultaneous endothelial keratoplasty requires several modifications in techniques.